The United Kingdom has decided to indefinitely ban the use of puberty blockers for under-18s experiencing gender dysphoria. 

Announced by the Department of Health and Social Care, the decision comes after a number of reviews and consultations with experts raised concerns over the safety and efficacy of the so-called “gender-affirming care.” 

Puberty blockers have been found to sterilize some children, who often accept them under mental duress, and without fully developed brains. 

In announcing the ban, Health Secretary Wes Streeting noted the decision was impacted by the Cass Review, an independent study into gender identity services for children under 18, which found the evidence base for these treatments to be “remarkably weak.”

“The safety of children must come first,” Streeting said.

He later added: “Evidence should have been established before they were ever prescribed for this purpose… it is a scandal.”

In fact, the NHS stated in March what many have been saying all along — that puberty blockers have irreversible effects on children.

The development also comes just weeks after a researcher who was attempting to prove the efficacy of giving puberty blockers to so-called trans-kids admitted to burying the study after the results were contrary to what she had hoped.

Advocates for giving puberty blockers to kids with gender dysphoria typically say it’s a matter of life and death, suggesting the kid will commit suicide unless they receive the hormones.

However, the Liberal Government recently acknowledged a significant gap in data regarding actual suicide mortality rates among trans and gender-diverse individuals in Canada. 

Additionally, a massive study published in June, one that spans 15 years and 2,772 children, revealed that most kids with gender dysphoria eventually outgrow their mental condition.